Broadcom Stock Drops 7.55% as Macquarie Downgrades Amid Broad Analyst Reshuffling
By TrendSpider Editor
Broadcom Inc. (AVGO) is under heavy pressure on Friday, falling 7.55% to $387.275 as a wave of 17 analyst actions hits the tape, headlined by a downgrade from Macquarie to "hold" with a price target of $437. Despite the broader analyst community remaining largely constructive, the single downgrade a
Broadcom Stock Drops 7.55% as Macquarie Downgrades Amid Broad Analyst Reshuffling
Broadcom Inc. (AVGO) is under heavy pressure on Friday, falling 7.55% to $387.275 as a wave of 17 analyst actions hits the tape, headlined by a downgrade from Macquarie to "hold" with a price target of $437. Despite the broader analyst community remaining largely constructive, the single downgrade and the stock's sharp intraday decline are drawing attention, particularly given that shares are now trading well below the consensus average price target of $509.35 and closer to the lower end of the 52-week range of $241.11 to $495. With AVGO sitting roughly 22% off its 52-week high, today's move raises questions about near-term momentum even as the long-term bull thesis remains intact among most covering analysts.
Key Drivers of the AVGO Stock Move
- Main Catalyst: Macquarie analyst Arthur Lai downgraded AVGO to "hold" with a price target of $437, making it the sole firm out of 17 to cut its rating on the stock today. The downgrade stands in contrast to 13 firms that confirmed "buy" ratings and 3 that maintained "hold" positions, underscoring that the bearish call is an outlier rather than a consensus shift.
- Bull Case: The overwhelming majority of analysts remain bullish, with JP Morgan's Harlan Sur carrying the Street-high price target of $580 and multiple firms raising targets, including Bank of America (up to $530 from $450), Oppenheimer (up to $535 from $450), Deutsche Bank (up to $515 from $430), and Keybanc (up to $575 from $500). The average price target of $509.35 implies more than 31% upside from current levels.
- Bear Case: Macquarie's $437 hold target is among the lowest on the Street alongside D.A. Davidson and RBC Capital, both at $400. UBS actually trimmed its target modestly to $485 from $490, adding a rare downward revision to an otherwise constructive day for price target adjustments. The stock's 7.55% single-session loss places it closer to its 52-week low of $241.11 than to the analyst consensus, suggesting the market may be pricing in risks that most analysts have yet to fully reflect.
Today's selloff and analyst action come against a backdrop of heightened scrutiny on AI-driven semiconductor names. Broadcom has been one of the primary beneficiaries of custom AI chip demand, and any sign of deceleration in hyperscaler capital expenditure commitments or competitive pressure from in-house chip design efforts could weigh on the outlook. The concentration of price target increases from firms like Oppenheimer and Bank of America suggests a recent earnings or guidance event may have provided a positive reset for many on the Street, yet the stock's failure to hold ground today indicates that investors may be digesting that information with more skepticism than the analyst community. The forward setup hinges on whether Broadcom can sustain its AI silicon pipeline and software integration story, which remains the core argument for the majority of buy-rated analysts with targets ranging from $500 to $580.
AVGO Analyst Ratings and Price Targets
A total of 17 analyst actions crossed the wire on Friday, June 6, 2026, with 1 downgrade and 0 upgrades. Macquarie's Arthur Lai was the lone dissenter, cutting to "hold" with a $437 price target. Among buy confirmations, JP Morgan's Harlan Sur holds the highest target at $580 (raised from $500), followed by Keybanc's John Vinh at $575 (raised from $500), Jefferies' Blayne Curtis at $550 (raised from $500), Truist Securities' William Stein at $550 (from $545), Benchmark's Cody Acree at $545 (from $485), Oppenheimer's Rick Schafer at $535 (from $450), and Cantor Fitzgerald's C.J. Muse at $525. Bank of America's Vivek Arya raised to $530 from $450 and Mizuho's Vijay Rakesh lifted to $530 from $480. Morgan Stanley's Joseph Moore confirmed buy at $502 (from $485) and Deutsche Bank's Ross Seymore raised to $515 from $430. TD Cowen's Joshua Buchalter held at $500, as did Rosenblatt's Kevin Cassidy. On the hold side, D.A. Davidson's Gil Luria set a target of $400 (from $375) and RBC Capital's Mitch Steves moved to $400 from $360. UBS trimmed its target to $485 from $490 while maintaining a buy. The consensus rating skews heavily toward buy, with an average price target of $509.35.
AVGO Seasonality
Historically, semiconductor stocks have exhibited mixed performance in early June as investors reposition ahead of mid-year portfolio rebalancing and ahead of major industry conferences that often serve as catalysts. For AVGO specifically, periods of broad analyst reaffirmation have sometimes preceded consolidation phases before the next leg higher.
AVGO Relative Performance
A single-session decline of 7.55% to $387.275 puts Broadcom among the notable underperformers in the semiconductor space on Friday. With its 52-week range spanning $241.11 to $495, the stock is currently trading approximately 21.8% below its 52-week high, suggesting the recent move has erased a meaningful portion of prior gains. Investors will be watching whether AVGO can stabilize near current levels or if the selling pressure persists relative to broader chip sector peers.
More on AVGO
- Broadcom Unusual Options Alert: A Deep ITM Put and Dual ATM Call Sweeps Signal Mixed Conviction
- Broadcom Put Activity Surges With $1.7M in Bearish Contracts as AVGO Climbs 2.59%
- Broadcom Sees $1.6 Million Bullish Call Bet as AVGO Trades Near 52-Week Lows
- Broadcom Sees $3.5 Million in Bearish Put Activity as Stock Hovers Near 52-Week Lows
- Broadcom Crushes Q3 2026 Earnings With 96% Profit Surge as Revenue Tops $29.5 Billion
Latest Market News
- Abbott Laboratories Matches Q3 EPS Estimates While Revenue Tops Forecasts, Stock Holds Steady
- Texas Instruments Crushes Q3 2026 Estimates With 77% Earnings Surge, But Stock Barely Moves
- Philip Morris International Tops Q3 2026 Estimates on EPS and Revenue, Shares Hold Near 52-Week Highs
- Pivotal Research Trims NFLX Price Target to $65 as Stock Hovers Near 52-Week Lows
- Tesla Beats Q3 2026 EPS by 20% But Shares Slide 3% as Revenue Growth Stalls
- Procter & Gamble Tops Q1 2027 Earnings Estimates, Shares Surge Toward 52-Week High